Price range: $95.00 through $150.00
Free bacteriostatic water with every order.
Use our Research Peptide Storage Guide — Laboratory Use Only — to ensure proper handling and stability for controlled experimental applications. Not for human consumption, therapeutic, or diagnostic use.
Chemical Formula: Sequence-dependent (GLP-2 analogue–based structure)
Molecular Weight: ~3,000–4,500 g/mol (dependent on modifications)
CAS Number: Research designation / Assigned upon structural registration
Structure: Engineered GLP-2–derived peptide analogue designed to enhance intestinal receptor activation and metabolic stability
Form: Lyophilized peptide powder
Solubility: Soluble in sterile water or buffered aqueous solution
Stability: Stable when frozen; limited stability after reconstitution
Half-Life: Extended relative to native GLP-2 due to structural stabilization
Storage: Store refrigerated at 36–46°F (2–8°C); protect from light and moisture
Binds to GLP-2 receptors expressed in intestinal tissues to stimulate trophic and protective signaling
Promotes epithelial cell proliferation and enhances gut lining integrity
Strengthens tight junction proteins and reduces intestinal permeability in research models
Supports improved intestinal surface area and absorption efficiency
Studied for improving mucosal healing in models of gut injury and inflammation
Investigated for reducing leaky gut markers and strengthening epithelial function
Explored for reducing intestinal inflammatory signaling and tissue damage
Evaluated for enhancing nutrient uptake and supporting gastrointestinal structural health
Preclinical research demonstrates:
Increased intestinal villus height
Enhanced crypt cell proliferation
Accelerated healing of mucosal injury models
Studies indicate:
Improved epithelial barrier integrity
Reduced intestinal permeability (“leaky gut” markers)
Increased tight junction protein expression
Evidence suggests:
Improved nutrient absorption efficiency
Support for weight maintenance during intestinal stress
Enhanced gut–brain signaling modulation
Research shows:
Reduced inflammatory cytokine expression in gut models
Protection against chemically induced intestinal injury
Improved recovery from inflammatory bowel models
Effects appear dose-dependent and typically resolve after the peptide’s active pharmacological period.
Temporary abdominal bloating, mild gastrointestinal discomfort
Fluid shifts due to enhanced intestinal activity
Safety information is primarily derived from preclinical and approved GLP-2 analogue research.
Dosing is generally individualized and titrated based on response and tolerability
Independent laboratory testing confirms purity and composition
Purity
Batch
Date
